Insider filing · VCYT
Karin Eastham
Director
profile →
Veracyte, Inc.
VCYT · Healthcare · 48 filings in 24 months
ticker →
Karin Eastham sold $403K of Veracyte (VCYT)
Executed Jan 2 2025, disclosed Jan 6 2025, 4 days later.
Value, as filed
$403K
10,000 sh across 2 lots
Executed
Jan 2 2025
the trade date, as filed
Disclosed
Jan 6 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
KEKarin Eastham (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $872K of VCYT (19,200 sh across 2 lots, as filed), executed Dec 5 2025.
The name
VCYTHealthcare · Veracyte, Inc. operates as a diagnostics company in the United States and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Karin Eastham in VCYT
VCYTSALE
Veracyte, Inc.
$169K3,200 sh × $52.78
Exec Jun 18
Filed Jun 22 · 5:30 PM ET VCYTSALE Veracyte, Inc. $872K
19,200 sh across 2 lots
Exec Dec 5 2025
Filed Dec 8 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. $387K
9,674 sh × $40.02
Exec Nov 5 2025
Filed Nov 7 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. $122K
4,590 sh × $26.66
Exec Jun 13 2025
Filed Jun 17 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. $506K
13,131 sh across 2 lots
Exec Nov 19 2024
Filed Nov 21 2024 · 5:30 PM ET